Clinical research on application of transluminal renal arterial catheter radiofrequency ablation for blood pressure reduction in patients with drug-resistant essential hypertension - Renal arterial catheter ablation for drug-resistant essential hypertension

Department of Advanced Cardiovascular Therapeutics, Osaka University Graduate School of Medicine0 个研究点目标入组 6 人开始时间: 2013年2月11日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Renal anomaly or incompetency: Narrowing, previous renal angioplasty or stenting, or bifurcation. 2) Estimated glomerular filtration ratio less than 45mL/min. 3) Myocardial infarction, angina pectoris, or cerebrovascular disorder within recent 6 months. 4) Type 1 diabetes. 5) Secondary hypertension. 6) Prominent bleeding risk or coagulating disorder. 7) Diagnosed as any non-cardiovascular disease with less than 12 months more to live. 8) Current participants for any other clinical trial, excluding under extended observation period for evaluating approved drugs or materials. 9) Pregnancy. 10) Disqualified by any cardiologist for participating in this study.

发起方

Department of Advanced Cardiovascular Therapeutics, Osaka University Graduate School of Medicine